Early research (Phase 1)Not Yet RecruitingNCT07724431
What this trial is testing
A Phase 1, Double-blind, Randomized Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Dose and Multiple Doses of CG-0416 in Healthy Participants.
Who this might be right for
Overweight and Obesity
HongKong Curegene Innovation Co., Limited 64